Skip to main content
Compare/P96 vs T39

P96 vs T39

P96 (Other conditions originating in the perinatal period) compared with T39 (Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).

Can these codes be reported together?

Yes, when both are documented. T39 carries an Excludes2 note covering P96: “drug reaction and poisoning affecting newborn (P00-P96)”

Excludes2 marks distinct conditions — both may be reported when both are documented.

Side by side

P96Other conditions originating in the perinatal periodT39Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics
Billing statusNon-billable header

Report instead: P96.0, P96.1, P96.2, P96.3, P96.5

Non-billable header

Report instead: T39.011A, T39.011D, T39.011S, T39.012A, T39.012D

ClassificationP00-P96 — Certain Conditions Originating in the Perinatal Period (P00-P96)S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88)
DefinitionOther conditions originating in the perinatal period is a non-billable ICD-10-CM category code (P96).Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics is a non-billable ICD-10-CM category code (T39).
7th characterThe appropriate 7th character is to be added to each code from category T39
Includes
adverse effect of correct substance properly administered
poisoning by overdose of substance
poisoning by wrong substance given or taken in error
underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Use additional code
code(s) to specify:
manifestations of poisoning
underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
Code first
, for adverse effects, the nature of the adverse effect, such as:
adverse effect NOS (T88.7)

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources